Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Anne Loft,Ana Jimena Alfaro,Søren Fisker Schmidt,Felix Boel Pedersen,Mike Krogh Terkelsen,Michele Puglia,Kan Kau Chow,Annette Feuchtinger,Maria Troullinaki,Adriano Maida,Gretchen Wolff,Minako Sakurai,Riccardo Berutti,Bilgen Ekim Üstünel,Peter Nawroth,Kim Ravnskjaer,Mauricio Berriel Diaz,Blagoy Blagoev,Stephan Herzig

DOI: https://doi.org/10.1016/j.cmet.2021.06.005

2021-08-03

Abstract:Liver fibrosis is a strong predictor of long-term mortality in individuals with metabolic-associated fatty liver disease; yet, the mechanisms underlying the progression from the comparatively benign fatty liver state to advanced non-alcoholic steatohepatitis (NASH) and liver fibrosis are incompletely understood. Using cell-type-resolved genomics, we show that comprehensive alterations in hepatocyte genomic and transcriptional settings during NASH progression, led to a loss of hepatocyte identity. The hepatocyte reprogramming was under tight cooperative control of a network of fibrosis-activated transcription factors, as exemplified by the transcription factor Elf-3 (ELF3) and zinc finger protein GLIS2 (GLIS2). Indeed, ELF3- and GLIS2-controlled fibrosis-dependent hepatokine genes targeting disease-associated hepatic stellate cell gene programs. Thus, interconnected transcription factor networks not only promoted hepatocyte dysfunction but also directed the intra-hepatic crosstalk necessary for NASH and fibrosis progression, implying that molecular "hub-centered" targeting strategies are superior to existing mono-target approaches as currently used in NASH therapy.